Search Results - "Ruiz, I. Victoria"
-
1
JS02.6.A PRELIMINARY SIGNS OF CLINICAL ACTIVITY OF TUVUSERTIB (M1774), A HIGHLY POTENT ORAL ATR INHIBITOR, IN REFRACTORY IDH MUTATED GLIOMA PATIENTS WITH P53 AND ATRX MUTATIONS; A CASE SERIES FROM A FIH STUDY
Published in Neuro-oncology (Charlottesville, Va.) (17-10-2024)Get full text
Journal Article -
2
125P Assessing the accuracy of multiple prognostic scores for immune checkpoint inhibitors (ICI) in patients with advanced solid tumors
Published in Annals of oncology (01-09-2022)Get full text
Journal Article -
3
116P Real-world and in silico incidence of fibroblast growth factor receptor (FGFR) 1-4 molecular alterations across multiple cancer types
Published in Annals of oncology (01-09-2021)Get full text
Journal Article -
4
-
5
109P Subpopulations of peripheral blood lymphocytes and response to immunotherapy across cancer-types
Published in Annals of oncology (01-09-2020)Get full text
Journal Article -
6
548P Molecular pre-screening using comprehensive gene panels offered by clinical trials (CT)
Published in Annals of oncology (01-09-2020)Get full text
Journal Article -
7
-
8
-
9
852PCAN RADIOLOGICAL PARAMETERS PREDICT THE OUTCOME IN METASTATIC RENAL CELL CARCINOMA (MRCC) PATIENTS TREATED WITH SUNITINIB? USEFULNESS OF NORMALIZED ARTERIAL DENSITY AND BLOOD FLOW
Published in Annals of oncology (01-09-2014)“…Abstract Aim: Despite of the efforts, clinically useful biomarkers in mRCC remain unknown. The aim is to determine if radiological parameters can be useful to…”
Get full text
Journal Article -
10
11P Influence of ctDNA variant allele frequency (VAF) on survival outcomes in metastatic breast cancer (MBC)
Published in ESMO open (01-05-2024)Get full text
Journal Article